Read this new comprehensive review in Nature Reviews Clinical Oncology that provides a integrated roadmap for #meningioma care as well as a framework for ongoing and future #research in this field.
go.nature.com/4tbNChI
Read more about @gelarehzadeh.bsky.social research on ‘Decoding the #immunological landscape of #meningioma to identify new #treatment targets’ with the Brain Tumour Charity:
bit.ly/4m8n7aa
🧠 Meningioma Research Highlights - Mar 2026
• Panobinostat shows efficacy in 70% of meningioma organoids
• PD-L1 positivity flags hyperaggressive meningioma subgroup
• Molecular-morphologic classification improves radiotherapy timing
pir.sh/nKzaE7Q1Jp
#Meningioma #Neurooncology
‘A microenvironment-determined risk continuum refines #subtyping in #meningioma and reveals determinants of #MachineLearning-based tumor classification’ is now out in Nature Genetics:
go.nature.com/4v2Hlq1
Read the article “A case of #radiation treatment effect mimicking viable, recurrent #meningioma on #DOTATATE PET imaging” in #NeuroOncology Advances:
bit.ly/4c4lsQ2
Our latest #newsletter has the most recent published #meningioma research from our #ICOM members.
Browse through the digital newsletter here: adobe.ly/4kmXBgz
This study found that for primary brain and other central nervous system mortalities occurring in 2018, #meningioma had the highest total years of life lost among nonmalignant #CNStumors (2.9% of all primary CNS tumor YLL; mYLL = 14.4 years).
Read more: bit.ly/4tl9Z4S
Thank you to the organizers, speakers, and attendees for helping make last week’s @NASBSorg #ICOM #Meningioma Education Day such a success!
MRI scan showing a meningioma.
The extra dose of progesterone from the birth control shot adds fuel for a #meningioma to develop. More on the increased risk compared to others associated with birth control & pregnancy: braintumorcenter.ucsf.edu/news/meningi...
@ucsfcancer.bsky.social @ucsfradonc.bsky.social @ucsfbixby.bsky.social
Join Dr. Christina Jackson during #Meningioma Education Day for her talk on Immunotherapy for Meningioma.
Dr. Jackson is a neurosurgeon at @upenn.edu specializing in open skull base surgery, minimally invasive surgery, endoscopic skull base & pituitary surgery, and complex brain tumor surgery
For those joining us for #Meningioma Education Day at #NASBS2026 next week, here’s the agenda for exciting sessions throughout the day!
bit.ly/4jm1qlT
Meningiomas are the most common primary #braintumor, occurring 2-4X more often in women than men. To learn more, tune in #WBAL-TV11 tonight, 2/23, 5:25pm as Mercy neurosurgeon Dr. Jon McIver appears on "The Woman's Doctor" to discuss. #meningioma @wbaltv11.bsky.social
mdmercy.com/find-a-docto...
Join Dr. Paul Gardner during our Meningioma Education Day where he will be speaking on Corridors of Approach: The modern approach to #SkullBase #meningioma surgery.
Dr. Gardner is a #neurosurgeon at @nyuniversity specializing in neurosurgery and treating skull base tumors.
“Biomarker testing helped me understand my #braintumor, eased fears for my daughters, and gave me confidence in decisions about my care. We need more awareness of #biomarkertesting.” — Amanda D.
Read her story: https://bit.ly/4r8U4Fd
#MyTumorID #meningioma
Dr. Osaama Khan will be speaking at our #Meningioma Education Day on label-free intraoperative meningioma diagnosis using Stimulated Raman Histology.
Dr. Khan is a neurosurgeon at Northwestern University focusing on Neurological Surgery and Neurosurgical Oncology.
Join Dr. Georgios Zenonos during our #Meningioma Education Day where he will be speaking on Approach selection and technical nuances for suprasellar meningiomas.
Dr. Zenonos is a #neurosurgeon at University of Pittsburgh focusing on Vascular and Brain and Tumor Neurosurgery and Skull Base Surgery
🧠 Meningioma — Jan 2026
• Targeted therapies show mixed results in NF2-mutant disease
• Epigenetic loss (H3K27me3) refines recurrence risk
• AI imaging and intraoperative tools enhance classification and decision-making
#Meningioma #NeuroOncology #BrainTumors
pir.sh/pzy1bVy1lv
🧠 Now published in Neuro-Oncology: “The prognostic impact of CDKN2A/B hemizygous deletions in #meningioma.” This new study, led by Franziska M. Ippen, builds on preliminary results previously presented at #EANO in Glasgow.
🔗 Learn more: doi.org/10.1093/neuo...
#EANOessentials #NeuroOncology
We are pleased to have @JamieVanGompel giving a talk on ‘Noninvasive imaging for #Meningioma: What we can learn’ at ICOM/NASBS Meningioma Education Day.
Dr. Van Gompel is a #neurosurgeon at @MayoClinic with a clinical focus on skull base tumours.
www.nasbs.org/icom-meningi...
🧠 Just published in Nature Genetics: "A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning–based tumor classification."
🔗 www.nature.com/articles/s41...
#EANOessentials #NeuroOncology #Meningioma #MachineLearning #OpenAccess
Epigenetics Update - A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classification go.nature.com/4aHhxra
#Epigenetics #Meningioma #Cancer
---
Gain deeper insights into gene regulation; epigenometech.com
Our Q1 #newsletter is now out!
Read about new #meningioma research and events here: indd.adobe.com/view/efac573...
When Tim’s double vision wouldn’t go away, it led to a #meningioma diagnosis, brain surgery, and radiation at just 27.
Years later, recurrence and scanxiety remain.
Read why “benign is not fine” in Tim’s story: braintumor.org/news/tims-story-scanxiet...
Thank you to the organizers of our upcoming NASBS/ICOM #Meningioma Education Day, @gelarehzadeh.bsky.social, Alex Landry, Farshad Nassiri, Michael Ivan, and Paul Gardner.
You can learn more about the agenda or register as part of the #NASBS 2026 Meeting here: bit.ly/4jm1qlT
This recent study found that #mebendazole reduced #meningioma cell invasion via Rho GTPase signalling and altered cytoskeletal dynamics in both male and female patient-derived spheroids.
Read more here: bit.ly/4rpAPXE
Meet us in San Diego for our #NASBS #ICOM #Meningioma Education Day!
We have a packed agenda for March 5, with exciting topics including #AugmentedReality for complex surgical planning, intraoperative molecular diagnosis
#AI, and more.
bit.ly/45iW9FQ
ICYMI, here is the top JNO Article on Social Media from December 2025: Optic Nerve Sheath Meningiomas: A Retrospective Cohort Study Comparing Outcomes in Treated Versus Observed Patients
Article: bit.ly/JNO_ONSM_VA
#brain #eye #vision #research #RadOnc #MRI #Meningioma
We have a great agenda for our #NASBS #ICOM #Meningioma Education Day!
Take a look, and register as part of the NASBS 2026 Annual Meeting March 5-8:
bit.ly/45iW9FQ
The full article “Long-term outcomes of active surveillance after #DOTATATE PET/MRI–confirmed gross total resection in WHO grade 2 #meningioma” is now available.
Read the article in #NeuroOncology Advances: bit.ly/4qQR4gn
“At least it’s benign.”
For Amanda, those words didn’t match the reality of living with a #braintumor. She shares why benign is not fine and how her #meningioma diagnosis had a lasting impact on her life.
Read Amanda’s story: braintumor.org/news/how-a-benign-brain-...
